Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Time to Focus on Alexion (ALXN) for Strong Earnings Growth Potential
Yahoo/Zacks.com
Wednesday, March 26, 2014 - 8:04am
tags:
earnings, Alexion
Insmed's lung infection drug fails mid-stage study
Yahoo/Reuters
Wednesday, March 26, 2014 - 8:03am
tags:
Insmed, Arikace, nontuberculous mycobacterial lung infections
GSK melanoma drug combination faces delay in Europe
Yahoo/Reuters
Wednesday, March 26, 2014 - 8:01am
tags:
GSK, Europe, melanoma, Mekinist, Tafinlar
3 Biotechs Expecting Top Line Phase 2 Data Mid 2014
Seeking Alpha
Wednesday, March 26, 2014 - 7:59am
tags:
Biota Pharmaceuticals, Laninamivir Octanoate, Flu, Inovio, VGX-3100, DNA vaccines, MultiStem, Athersys, Pfizer, ulcerative colitis
Biogen cozies up to MIT with a $5.3M drug discovery pact
Fierce Biotech
Tuesday, March 25, 2014 - 9:44pm
tags:
Biogen Idec, MIT, drug discovery
Sanofi's Getting Back in the Game
Yahoo/Guru Focus
Tuesday, March 25, 2014 - 8:03pm
tags:
Sanofi, patents, Lemtrada
Gilead Following Multiple Paths Toward HIV “Functional Cure”
Motley Fool
Tuesday, March 25, 2014 - 8:01pm
tags:
Gilead Sciences, HIV
Dendreon Ready For A Rebound
Seeking Alpha
Tuesday, March 25, 2014 - 7:59pm
tags:
Dendreon
FDA: More Than 3.4 Million Hours Spent Each Year Filing New and Generic Drug Applications
Regulatory Focus
Tuesday, March 25, 2014 - 10:25am
tags:
FDA
Pfizer lung cancer drug beats chemo for previously untreated patients
Yahoo/Reuters
Tuesday, March 25, 2014 - 10:00am
tags:
Pfizer, Xalkori, lung cancer
The 10 best-selling drugs of 2013
Fierce Pharma
Tuesday, March 25, 2014 - 9:56am
tags:
Seretide, Rituxan, Remicade, MabThera, Lantus, Humira, Herceptin, Enbrel, Crestor, Avastin, Advair, Abilify
AbbVie CEO's pay doubles to $18.2M in Abbott pharma spinoff's first solo year
Fierce Pharma
Tuesday, March 25, 2014 - 9:54am
tags:
AbbVie, Pharma CEOs, executive pay, Richard Gonzalez
FDA staff review recommends against Novartis heart failure drug
Yahoo/Reuters
Tuesday, March 25, 2014 - 8:36am
tags:
FDA, Novartis, acute heart failure, serelaxin, advisory panels, S
Halozyme Announces Positive Results From Phase 1/2 Clinical Trial In Cellulite With HTI-501
Yahoo
Tuesday, March 25, 2014 - 8:25am
tags:
Halozyme, clinical trials, cellulite, HTI-501
Sanofi faces make-or-break verdict on big dengue vaccine bet
Yahoo/Reuters
Tuesday, March 25, 2014 - 8:23am
tags:
Sanofi, dengue, vaccines
Zohydro: Should Politicians Be Able To Overturn An FDA Decision?
Seeking Alpha
Tuesday, March 25, 2014 - 8:22am
tags:
Zohydro, FDA, Zogenix, hydrocodone
FDA updates medtech fast-track review for rare treatments
Mass Device
Tuesday, March 25, 2014 - 8:09am
tags:
FDA, fast track, devices
Who's going to win pharma's immunotherapy gold rush?
Fierce Biotech
Tuesday, March 25, 2014 - 8:08am
tags:
immunotherapy, Roche, Bristol-Myers Squibb, Merck, PDL-1, anti-PD-1 immunotherapy, melanoma
Final NICE guidance rejects Sanofi's Zaltrap in colorectal cancer
First Word Pharma
Tuesday, March 25, 2014 - 8:06am
tags:
NICE, Sanofi, colorectal cancer, Zaltrap
Will The Hep-C Drug, Sovaldi, Drive Gilead To The Top Of The Biopharm Industry?
Forbes
Tuesday, March 25, 2014 - 8:05am
tags:
hepatitis C, Gilead Sciences, Sovaldi

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.